The only therapy available for people with leprechaunism to date is recombinant IGF1, aiming to forestall compensatory hyperinsulinemia (23). IGF has about the 6% with the glucose-lowering action effect of insulin and has an identical framework to it, thus it is able to bind to insulin receptors triggering peripheral https://radiantease49764.idblogz.com/28093637/the-basic-principles-of-insulin-ressitance